Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Transplantation Direct
|
October 3, 2019
Excellent Contemporary Graft Survival for Adult Liver Retransplantation: An Australian and New Zealand Registry Analysis From 1986 to 2017
Angus W Jeffrey, Luc Delriviere, Geoff McCaughan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
Darren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
The New Zealand Medical Journal
|
March 24, 2009
Live donor liver transplantation in New Zealand: a report on the first 20 cases
John McCall, Margaret Johnston, Barry Harrison, et al.
European Journal of Gastroenterology & Hepatology
|
June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection
Adrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.
Plos One
|
June 17, 2021
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Plos One
|
March 27, 2020
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Gut
|
October 18, 2015
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders
Kumar Visvanathan, Geoff Dusheiko, Michelle Giles, et al.
The Lancet. Gastroenterology & Hepatology
|
January 19, 2026
ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial
Man-Fung Yuen, Kosh Agarwal, Alina Jucov, et al.
Antiviral Therapy
|
June 13, 2022
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B
Ed Gane, Man-Fung Yuen, Thomas N Kakuda, et al.
Gastroenterology
|
March 8, 2014
Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial
Xavier Forns, Eric Lawitz, Stefan Zeuzem, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Transplantation Direct
|
October 3, 2019
Excellent Contemporary Graft Survival for Adult Liver Retransplantation: An Australian and New Zealand Registry Analysis From 1986 to 2017
Angus W Jeffrey, Luc Delriviere, Geoff McCaughan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
Darren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
The New Zealand Medical Journal
|
March 24, 2009
Live donor liver transplantation in New Zealand: a report on the first 20 cases
John McCall, Margaret Johnston, Barry Harrison, et al.
European Journal of Gastroenterology & Hepatology
|
June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection
Adrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.
Plos One
|
June 17, 2021
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Plos One
|
March 27, 2020
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Gut
|
October 18, 2015
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders
Kumar Visvanathan, Geoff Dusheiko, Michelle Giles, et al.
The Lancet. Gastroenterology & Hepatology
|
January 19, 2026
ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial
Man-Fung Yuen, Kosh Agarwal, Alina Jucov, et al.
Antiviral Therapy
|
June 13, 2022
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B
Ed Gane, Man-Fung Yuen, Thomas N Kakuda, et al.
Gastroenterology
|
March 8, 2014
Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial
Xavier Forns, Eric Lawitz, Stefan Zeuzem, et al.
Page
of 8